Patents by Inventor Stian FOSS

Stian FOSS has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ENGINEERED IMMUNOGLOBULINS WITH ALTERED FCRN BINDING
    Publication number: 20220348690
    Abstract: The present invention relates to compositions and methods for antibody-mediated therapy. In particular, provided herein are engineered immunoglobulins with altered half-life.
    Type: Application
    Filed: April 12, 2022
    Publication date: November 3, 2022
    Applicant: UNIVERSITETET | OSLO
    Inventors: Jan Terje ANDERSEN, Stian FOSS, Inger SANDLIE
  • Engineered immunoglobulins with altered FcRn binding
    Patent number: 11319383
    Abstract: The present invention relates to compositions and methods for antibody-mediated therapy. In particular, provided herein are engineered immunoglobulins with altered half-life.
    Type: Grant
    Filed: March 14, 2017
    Date of Patent: May 3, 2022
    Assignee: Universitetet | Oslo
    Inventors: Jan Terje Andersen, Stian Foss, Inger Sandlie
  • ENGINEERED IMMUNOGLOBULINS WITH ALTERED FCRN BINDING
    Publication number: 20190077883
    Abstract: The present invention relates to compositions and methods for antibody-mediated therapy. In particular, provided herein are engineered immunoglobulins with altered half-life.
    Type: Application
    Filed: March 14, 2017
    Publication date: March 14, 2019
    Applicant: UNIVERSITETET I OSLO
    Inventors: Jan Terje ANDERSEN, Stian FOSS, Inger SANDLIE